Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
S-Biomedic from Gent, company number BE0668407105, closed financial year 2025 with a result of € 259,601 after tax. For that financial year S-Biomedic recorded a gross margin of € 4.4 million and equity of € 1.9 million. Compared with financial year 2024, the result moved from € -750,941 to € 259,601. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 1.9 million
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 259,601
▲ still € 750,941 loss in 2024
Profit after tax over the fiscal year.
€ 2.8 million
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -412,550.
People and assets in 2025
12.2
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.3 million
▲ 14% vs 2024
€ 109,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 18,773
▲ 80% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 370,983
▼ 85% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 244,919
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -2,949,357 | € 3,047,035 | € 2,992,049 | € 4,448,256 | ▲ 49% |
| Profit after taxes | € -6,136,291 | € 78,791 | € -750,941 | € 259,601 | ▲ € 1 million |
| Equity | € 2,266,238 | € 2,345,029 | € 1,594,087 | € 1,853,688 | ▲ 16% |
| Total debts | € 4,639,766 | € 6,028,586 | € 6,339,542 | € 4,081,835 | ▼ 36% |
| Cash | € 5,269,801 | € 4,834,951 | € 3,856,453 | € 2,808,448 | ▼ 27% |
| Retained profit | € -10,238,133 | € 1,616,377 | € -672,151 | € -412,550 | ▲ € 259,601 |
| Balance sheet total | € 6,906,004 | € 8,373,614 | € 7,933,629 | € 5,935,523 | ▼ 25% |
| Employees (FTE) | 12.3 | 11.4 | 11.5 | 12.2 | ▲ 0.7 |
Key figures of S-Biomedic, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to S-Biomedic?
What happened at S-Biomedic in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dr. Gitta Neufang stepped down as director. NBB
- Christopher Sheldon stepped down as director. NBB
- Dr. Stefan Gallinat stepped down as director. NBB
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- Dr. Gitta Neufang became a director. NBB
- Christopher Sheldon became a director. NBB
- Dr. Stefan Gallinat became a director. NBB
- New establishment in Gent. KBO
In short
From € 6.1 million loss in 2022 to € 259,601 profit in 2025.
Best year ever: 2025, with € 259,601 profit.
On average € 364,600 of value added per employee in 2025.
Management
Directors
According to the 2025 annual accounts
Dr. Gitta Neufang
Director
since 2022 · until 2028
Christopher Sheldon
Director
since 2022 · until 2028
Dr. Stefan Gallinat
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
ORIONIS BIOSCIENCES
€ 11.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
272BIO
€ 104,252 gross margin · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
SQUARESPACE - Squarespace, Inc., US
DNS
GoDaddy DNS
Domain
Domain
sbiomedic.com
Registered
2014-06-23
Registrar
Mesh Digital Limited
Expires
2026-06-23
Website info
Features
Security
Network
Details
- Company number
- 0668.407.105
- VAT number
- BE 0668.407.105
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- S-Biomedic
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2016
- Peppol
- Active · Active since 2 Dec 2025
- Contact
- sbiomedic.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Markt- en opinieonderzoek